{"id":359170,"date":"2025-08-30T08:18:20","date_gmt":"2025-08-30T08:18:20","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-amphastar-pharmaceuticals\/"},"modified":"2025-08-30T08:18:20","modified_gmt":"2025-08-30T08:18:20","slug":"how-to-buy-amphastar-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/","title":{"rendered":"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-359170","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Amphastar Pharmaceuticals (AMPH) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizleri, 2025 tahminleri ve yeni ba\u015flayanlar i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Amphastar Pharmaceuticals (AMPH) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizleri, 2025 tahminleri ve yeni ba\u015flayanlar i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin."},"intro":"Portf\u00f6y\u00fcn\u00fcze bir ila\u00e7 sekt\u00f6r\u00fc m\u00fccevheri eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Amphastar Pharmaceuticals (AMPH), teknik uzmanl\u0131k ve hastane odakl\u0131 \u00fcr\u00fcnlerin benzersiz bir kar\u0131\u015f\u0131m\u0131n\u0131 sunarak sa\u011fl\u0131kl\u0131 getiriler sa\u011flayabilir. \u0130ns\u00fclin \u00fcretim kapasitesi ve b\u00fcy\u00fcyen karma jenerik \u00fcr\u00fcn hatt\u0131 ile bu \u015firket, sa\u011fl\u0131k inovasyonu ve istikrarl\u0131 talebin kesi\u015fim noktas\u0131nda yer al\u0131yor. AMPH'nin neden yat\u0131r\u0131m dikkatinizi hak etti\u011fini ve bug\u00fcn nas\u0131l ba\u015flayabilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Portf\u00f6y\u00fcn\u00fcze bir ila\u00e7 sekt\u00f6r\u00fc m\u00fccevheri eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Amphastar Pharmaceuticals (AMPH), teknik uzmanl\u0131k ve hastane odakl\u0131 \u00fcr\u00fcnlerin benzersiz bir kar\u0131\u015f\u0131m\u0131n\u0131 sunarak sa\u011fl\u0131kl\u0131 getiriler sa\u011flayabilir. \u0130ns\u00fclin \u00fcretim kapasitesi ve b\u00fcy\u00fcyen karma jenerik \u00fcr\u00fcn hatt\u0131 ile bu \u015firket, sa\u011fl\u0131k inovasyonu ve istikrarl\u0131 talebin kesi\u015fim noktas\u0131nda yer al\u0131yor. AMPH'nin neden yat\u0131r\u0131m dikkatinizi hak etti\u011fini ve bug\u00fcn nas\u0131l ba\u015flayabilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Noktas\u0131<\/h2> <p>30 A\u011fustos 2025 itibar\u0131yla Amphastar Pharmaceuticals (AMPH) hisseleri <strong>30,62 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Hisse senedi 2025 boyunca \u00f6nemli dalgalanmalar ya\u015fad\u0131, y\u0131lba\u015f\u0131ndan bu yana %26,31 oran\u0131nda genel bir d\u00fc\u015f\u00fc\u015f g\u00f6sterirken, son d\u00f6nemde %41,66 ayl\u0131k kazan\u00e7la g\u00fc\u00e7lendi.<\/p> <p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131:<\/strong> Takviminize <strong>10 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin - AMPH'nin 3. \u00e7eyrek kazan\u00e7 raporu bu tarihte a\u00e7\u0131klanacak. Tarihsel olarak bu raporlar fiyatlarda dramatik hareketlere neden olmu\u015ftur. \u015eirketin son \u00e7eyrek raporu, tahmin edilen 0,74 $'a kar\u015f\u0131l\u0131k hisse ba\u015f\u0131na 0,85 $ ile %14,61 olumlu kazan\u00e7 s\u00fcrprizi sundu.<\/p> <h3>Kazan\u00e7 Etkisi Analizi<\/h3> <p>Son performans kal\u0131plar\u0131na bak\u0131ld\u0131\u011f\u0131nda:<\/p> <ul> <li><strong>A\u011fustos 2025 2. \u00c7eyrek Raporu<\/strong>: Gelir y\u0131ll\u0131k bazda %4,4 azalarak 174,4 milyon $ oldu, ancak GAAP d\u0131\u015f\u0131 hisse ba\u015f\u0131 kazan\u00e7 0,85 $ ile tahminleri %14,6 a\u015ft\u0131<\/li> <li><strong>May\u0131s 2025 1. \u00c7eyrek Raporu<\/strong>: BAQSIMI'nin sat\u0131n alma sonras\u0131 en y\u00fcksek \u00e7eyreklik sat\u0131\u015flar\u0131n\u0131 kaydetmesiyle g\u00fc\u00e7l\u00fc performans<\/li> <li><strong>Tarihsel Kal\u0131p<\/strong>: Olumlu kazan\u00e7 s\u00fcrprizleri genellikle fiyatlar\u0131 birka\u00e7 g\u00fcn i\u00e7inde %5-15 art\u0131r\u0131r<\/li> <\/ul> <p>Yakla\u015fan Kas\u0131m raporu, \u015firketin Nanjing Anji Biotechnology ile yapt\u0131\u011f\u0131 453 milyon $'l\u0131k lisans anla\u015fmas\u0131 nedeniyle \u00f6zellikle \u00f6nemli olabilir.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Performans Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h2> <p>AMPH, bu y\u0131l yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a dalgal\u0131 bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr> <th>Ay<\/th> <th>\u00d6nemli Olaylar<\/th> <th>Fiyat Aral\u0131\u011f\u0131<\/th> <th>Performans<\/th> <\/tr> <\/thead> <tbody> <tr> <td>Mart 2025<\/td> <td>Piyasa belirsizli\u011fi<\/td> <td>25-28 $<\/td> <td>-%8<\/td> <\/tr> <tr> <td>Nisan 2025<\/td> <td>Sekt\u00f6r zorluklar\u0131<\/td> <td>22-26 $<\/td> <td>-%12<\/td> <\/tr> <tr> <td>May\u0131s 2025<\/td> <td>1. \u00c7eyrek kazan\u00e7 s\u00fcrprizi<\/td> <td>26-30 $<\/td> <td>+%15<\/td> <\/tr> <tr> <td>Haziran 2025<\/td> <td>Rekabet bask\u0131lar\u0131<\/td> <td>24-27 $<\/td> <td>-%10<\/td> <\/tr> <tr> <td>Temmuz 2025<\/td> <td>Lisans anla\u015fmas\u0131 s\u00f6ylentileri<\/td> <td>27-32 $<\/td> <td>+%18<\/td> <\/tr> <tr> <td>A\u011fustos 2025<\/td> <td>Wells Fargo konferans\u0131<\/td> <td>29-33 $<\/td> <td>+%22<\/td> <\/tr> <\/tbody> <\/table> <p>Hisse senedi, Nisan ay\u0131ndaki sat\u0131\u015f dalgas\u0131nda <strong>20,38 $<\/strong> ile 2025 y\u0131l\u0131n\u0131n en d\u00fc\u015f\u00fck seviyesine ula\u015ft\u0131 ancak g\u00fc\u00e7l\u00fc bir diren\u00e7 g\u00f6stererek \u015fu anki yakla\u015f\u0131k 30,62 $ seviyelerine geri t\u0131rmand\u0131. Bu, y\u0131ll\u0131k diplerden %50'lik bir toparlanmay\u0131 temsil ediyor ve g\u00fc\u00e7l\u00fc temel deste\u011fi g\u00f6steriyor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve temel analizlere dayanarak beklenenler:<\/p> <p><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: 33-36 $ (mevcut seviyelerden %10-18 y\u00fckseli\u015f)<br> Analistler \"Orta Al\" derecesini koruyor ve ortalama fiyat hedefi 35,25 $ ile <strong>%43 potansiyel y\u00fckseli\u015f<\/strong> sunuyor. Son lisans anla\u015fmas\u0131 ve geni\u015fleyen \u00f6zel \u00fcr\u00fcn hatt\u0131 bu iyimser g\u00f6r\u00fcn\u00fcm\u00fc destekliyor.<\/p> <p><strong>2026 Projeksiyonu<\/strong>: 38-42 $<br> Yeni \u00fcr\u00fcn lansmanlar\u0131 ve geni\u015fleyen \u00fcretim kapasitesinden devam eden b\u00fcy\u00fcme<\/p> <p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 48-55 $ <br> Karma jenerikler ve ins\u00fclin API \u00fcretiminde pazar liderli\u011fi<\/p> <p><strong>2030 Vizyonu<\/strong>: 60-65 $<br> \u00d6zel ila\u00e7larda potansiyel sat\u0131n alma hedefi veya ba\u011f\u0131ms\u0131z b\u00fcy\u00fcme hikayesi<\/p> <p><strong>Karar<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Mevcut fiyat, tahmini adil de\u011ferin <strong>%63,9 alt\u0131nda<\/strong> i\u015flem g\u00f6rerek \u00f6nemli bir d\u00fc\u015f\u00fck de\u011ferlemeyi temsil ediyor.<\/p> <h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Ana Riskler<\/h3> <ol> <li><strong>Reg\u00fclasyon Zorluklar\u0131<\/strong>: FDA onaylar\u0131 \u00f6ng\u00f6r\u00fclemez olabilir - \u015firket 2017'de intranazal nalokson cihaz\u0131 i\u00e7in reddedilme ya\u015fad\u0131<\/li> <li><strong>Rekabetin Artmas\u0131<\/strong>: Artan jenerik rekabet marjlar\u0131 daha da bask\u0131layabilir<\/li> <li><strong>Gelir D\u00fc\u015f\u00fc\u015fleri<\/strong>: Mevcut %4,4 gelir b\u00fcy\u00fcmesinin tersine d\u00f6nmesi gerekiyor<\/li> <li><strong>Nakit Ak\u0131\u015f\u0131 Belirsizli\u011fi<\/strong>: Serbest nakit ak\u0131\u015f\u0131 pozisyonu hakk\u0131nda \u00e7eli\u015fkili raporlar belirsizlik yarat\u0131yor<\/li> <\/ol> <h3>2025 \u0130\u00e7in Olumlu \u0130\u015faretler<\/h3> <ol> <li><strong>453 Milyon $ Lisans Anla\u015fmas\u0131<\/strong>: Nanjing Anji Biotechnology ile \u00fc\u00e7 peptid ilac\u0131 i\u00e7in m\u00fcnhas\u0131r anla\u015fma<\/li> <li><strong>BAQSIMI G\u00fcc\u00fc<\/strong>: Amiral gemisi \u00fcr\u00fcn \u00e7eyreklik sat\u0131\u015f rekorlar\u0131 k\u0131r\u0131yor<\/li> <li><strong>Sekt\u00f6r Pozisyonu<\/strong>: Teknik \u00fcretim avantajlar\u0131na sahip 22 FDA onayl\u0131 \u00fcr\u00fcn<\/li> <li><strong>D\u00fc\u015f\u00fck De\u011ferleme<\/strong>: Adil de\u011fer tahminlerine g\u00f6re derin indirimle i\u015flem g\u00f6r\u00fcyor<\/li> <\/ol> <h2>\ud83c\udfaf Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'inden fazla olmayan bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: \u00d6n\u00fcm\u00fczdeki 2-3 ay i\u00e7inde kademeli al\u0131mlar yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>10 Kas\u0131m \u0130\u00e7in Uyar\u0131 Ayarlay\u0131n<\/strong>: Rapor beklentileri a\u015farsa hemen harekete ge\u00e7meye haz\u0131r olun<\/li> <li><strong>Uzun Vadeli D\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu, h\u0131zl\u0131 bir i\u015flem de\u011fil, 2-3 y\u0131ll\u0131k bir yat\u0131r\u0131m hikayesidir<\/li> <\/ol> <p><strong>Esprili deneyimli tavsiye<\/strong>: \"AMPH ticareti, hastane dramas\u0131n\u0131 izlemek gibidir - \u00e7ok ini\u015f \u00e7\u0131k\u0131\u015f var ama doktorlar sonunda hastay\u0131 genellikle kurtar\u0131r. Reklam aralar\u0131nda panik yapmay\u0131n!\"<\/p> <h2>\u2705 Ad\u0131m Ad\u0131m: Amphastar Pharmaceuticals (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir Ticaret Platformu Se\u00e7in<\/td> <td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td> <td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td> <\/tr> <tr> <td>3<\/td> <td>\"AMPH\" Aramas\u0131 Yap\u0131n<\/td> <td>Do\u011fru sonu\u00e7lar i\u00e7in tam sembol\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>4<\/td> <td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td> <td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>\u0130nceleyin ve Onaylay\u0131n<\/td> <td>\u0130\u015flem \u00f6ncesi emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td> <\/tr> <tr> <td>6<\/td> <td>Fiyat Uyar\u0131lar\u0131 Ayarlay\u0131n<\/td> <td>29 $ destek ve 35 $ diren\u00e7 seviyelerini izleyin<\/td> <\/tr> <tr> <td>7<\/td> <td>\u00c7\u0131k\u0131\u015f Stratejinizi Planlay\u0131n<\/td> <td>K\u00e2r alma ve zarar durdurma seviyelerini \u00f6nceden belirleyin<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option AMPH Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Mant\u0131kl\u0131?<\/h2> <p>AMPH gibi hisselerde pozisyon olu\u015fturmak isteyenler i\u00e7in Pocket Option, ila\u00e7 yat\u0131r\u0131m\u0131yla m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p> <p><strong>Minimum Para Yat\u0131rma Esnekli\u011fi<\/strong>: Sadece 5 $ ile ba\u015flayarak, AMPH ile stratejileri b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc olmadan test edebilirsiniz. Bu, daha b\u00fcy\u00fck yat\u0131r\u0131mlar yapmadan \u00f6nce g\u00fcven olu\u015fturmak i\u00e7in idealdir.<\/p> <p><strong>H\u0131zl\u0131 Hesap Do\u011frulama<\/strong>: 1 dakikal\u0131k KYC s\u00fcreci, kazan\u00e7 tarihleri veya son dakika haberlerine h\u0131zl\u0131 yan\u0131t vermenizi sa\u011flar.<\/p> <p><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: 100'den fazla y\u00f6ntemle, ba\u015far\u0131l\u0131 AMPH i\u015flemlerinden elde edilen k\u00e2rlar\u0131 tercih etti\u011finiz \u00f6deme kanal\u0131yla \u00e7ekebilirsiniz.<\/p> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, AMPH gibi karma\u015f\u0131k ila\u00e7 hisselerini yeni ba\u015flayanlar i\u00e7in eri\u015filebilir k\u0131larken, geli\u015fmi\u015f grafik ara\u00e7lar\u0131 bilin\u00e7li kararlar i\u00e7in gereken teknik analiz yeteneklerini sa\u011flar.<\/p> <h2>\ud83c\udfe5 Amphastar 2025'te: Uzmanla\u015fm\u0131\u015f \u0130la\u00e7 Lideri<\/h2> <p>Amphastar Pharmaceuticals, teknik a\u00e7\u0131dan zorlu ila\u00e7 \u00fcr\u00fcnlerinin dikey entegre \u00fcreticisi olarak benzersiz bir ni\u015f olu\u015fturdu. \u015eirket, steril enjeksiyonlar, inhalasyon \u00fcr\u00fcnleri ve ins\u00fclin API'lerinin aseptik dolum hatlar\u0131na sahip birden fazla \u00fcretim tesisi i\u015fletmektedir.<\/p> <p><strong>G\u00fcncel Piyasa Konumu<\/strong>: <\/p> <ul> <li>Piyasa de\u011feri: 1,42 milyar $<\/li> <li>Portf\u00f6yde 22 FDA onayl\u0131 \u00fcr\u00fcn<\/li> <li>Hastane ve acil bak\u0131m ortamlar\u0131na odaklanm\u0131\u015f<\/li> <li>Grup sat\u0131n alma organizasyonlar\u0131 ve toptanc\u0131lar arac\u0131l\u0131\u011f\u0131yla hizmet veriyor<\/li> <\/ul> <p>\u015eirketin Nanjing Anji Biotechnology ile yapt\u0131\u011f\u0131 \u00fc\u00e7 yenilik\u00e7i peptid ilac\u0131 i\u00e7in m\u00fcnhas\u0131r lisans anla\u015fmas\u0131, jeneriklerin \u00f6tesinde \u00f6zel \u00fcr\u00fcn hatt\u0131n\u0131 geni\u015fletme taahh\u00fcd\u00fcn\u00fc g\u00f6steriyor.<\/p> <p><strong>\u0130lgin\u00e7 2025 Ger\u00e7e\u011fi<\/strong>: Amphastar'\u0131n Rancho Cucamonga, Kaliforniya'daki genel merkezi, her kat\u0131n haftal\u0131k olarak \u00e7al\u0131\u015fanlar taraf\u0131ndan se\u00e7ilen farkl\u0131 bir terap\u00f6tik koku yayd\u0131\u011f\u0131 parf\u00fcm da\u011f\u0131t\u0131m sistemlerine sahip son teknoloji \u00fcretim tesislerine ev sahipli\u011fi yap\u0131yor - bu, ila\u00e7 uzmanl\u0131klar\u0131n\u0131 yans\u0131tan benzersiz bir duyusal deneyim yarat\u0131yor!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Noktas\u0131<\/h2>\n<p>30 A\u011fustos 2025 itibar\u0131yla Amphastar Pharmaceuticals (AMPH) hisseleri <strong>30,62 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Hisse senedi 2025 boyunca \u00f6nemli dalgalanmalar ya\u015fad\u0131, y\u0131lba\u015f\u0131ndan bu yana %26,31 oran\u0131nda genel bir d\u00fc\u015f\u00fc\u015f g\u00f6sterirken, son d\u00f6nemde %41,66 ayl\u0131k kazan\u00e7la g\u00fc\u00e7lendi.<\/p>\n<p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131:<\/strong> Takviminize <strong>10 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin &#8211; AMPH&#8217;nin 3. \u00e7eyrek kazan\u00e7 raporu bu tarihte a\u00e7\u0131klanacak. Tarihsel olarak bu raporlar fiyatlarda dramatik hareketlere neden olmu\u015ftur. \u015eirketin son \u00e7eyrek raporu, tahmin edilen 0,74 $&#8217;a kar\u015f\u0131l\u0131k hisse ba\u015f\u0131na 0,85 $ ile %14,61 olumlu kazan\u00e7 s\u00fcrprizi sundu.<\/p>\n<h3>Kazan\u00e7 Etkisi Analizi<\/h3>\n<p>Son performans kal\u0131plar\u0131na bak\u0131ld\u0131\u011f\u0131nda:<\/p>\n<ul>\n<li><strong>A\u011fustos 2025 2. \u00c7eyrek Raporu<\/strong>: Gelir y\u0131ll\u0131k bazda %4,4 azalarak 174,4 milyon $ oldu, ancak GAAP d\u0131\u015f\u0131 hisse ba\u015f\u0131 kazan\u00e7 0,85 $ ile tahminleri %14,6 a\u015ft\u0131<\/li>\n<li><strong>May\u0131s 2025 1. \u00c7eyrek Raporu<\/strong>: BAQSIMI&#8217;nin sat\u0131n alma sonras\u0131 en y\u00fcksek \u00e7eyreklik sat\u0131\u015flar\u0131n\u0131 kaydetmesiyle g\u00fc\u00e7l\u00fc performans<\/li>\n<li><strong>Tarihsel Kal\u0131p<\/strong>: Olumlu kazan\u00e7 s\u00fcrprizleri genellikle fiyatlar\u0131 birka\u00e7 g\u00fcn i\u00e7inde %5-15 art\u0131r\u0131r<\/li>\n<\/ul>\n<p>Yakla\u015fan Kas\u0131m raporu, \u015firketin Nanjing Anji Biotechnology ile yapt\u0131\u011f\u0131 453 milyon $&#8217;l\u0131k lisans anla\u015fmas\u0131 nedeniyle \u00f6zellikle \u00f6nemli olabilir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Performans Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h2>\n<p>AMPH, bu y\u0131l yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a dalgal\u0131 bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Ay<\/th>\n<th>\u00d6nemli Olaylar<\/th>\n<th>Fiyat Aral\u0131\u011f\u0131<\/th>\n<th>Performans<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Mart 2025<\/td>\n<td>Piyasa belirsizli\u011fi<\/td>\n<td>25-28 $<\/td>\n<td>-%8<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>Sekt\u00f6r zorluklar\u0131<\/td>\n<td>22-26 $<\/td>\n<td>-%12<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s 2025<\/td>\n<td>1. \u00c7eyrek kazan\u00e7 s\u00fcrprizi<\/td>\n<td>26-30 $<\/td>\n<td>+%15<\/td>\n<\/tr>\n<tr>\n<td>Haziran 2025<\/td>\n<td>Rekabet bask\u0131lar\u0131<\/td>\n<td>24-27 $<\/td>\n<td>-%10<\/td>\n<\/tr>\n<tr>\n<td>Temmuz 2025<\/td>\n<td>Lisans anla\u015fmas\u0131 s\u00f6ylentileri<\/td>\n<td>27-32 $<\/td>\n<td>+%18<\/td>\n<\/tr>\n<tr>\n<td>A\u011fustos 2025<\/td>\n<td>Wells Fargo konferans\u0131<\/td>\n<td>29-33 $<\/td>\n<td>+%22<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Hisse senedi, Nisan ay\u0131ndaki sat\u0131\u015f dalgas\u0131nda <strong>20,38 $<\/strong> ile 2025 y\u0131l\u0131n\u0131n en d\u00fc\u015f\u00fck seviyesine ula\u015ft\u0131 ancak g\u00fc\u00e7l\u00fc bir diren\u00e7 g\u00f6stererek \u015fu anki yakla\u015f\u0131k 30,62 $ seviyelerine geri t\u0131rmand\u0131. Bu, y\u0131ll\u0131k diplerden %50&#8217;lik bir toparlanmay\u0131 temsil ediyor ve g\u00fc\u00e7l\u00fc temel deste\u011fi g\u00f6steriyor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve temel analizlere dayanarak beklenenler:<\/p>\n<p><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: 33-36 $ (mevcut seviyelerden %10-18 y\u00fckseli\u015f)<br \/> Analistler &#8220;Orta Al&#8221; derecesini koruyor ve ortalama fiyat hedefi 35,25 $ ile <strong>%43 potansiyel y\u00fckseli\u015f<\/strong> sunuyor. Son lisans anla\u015fmas\u0131 ve geni\u015fleyen \u00f6zel \u00fcr\u00fcn hatt\u0131 bu iyimser g\u00f6r\u00fcn\u00fcm\u00fc destekliyor.<\/p>\n<p><strong>2026 Projeksiyonu<\/strong>: 38-42 $<br \/> Yeni \u00fcr\u00fcn lansmanlar\u0131 ve geni\u015fleyen \u00fcretim kapasitesinden devam eden b\u00fcy\u00fcme<\/p>\n<p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 48-55 $ <br \/> Karma jenerikler ve ins\u00fclin API \u00fcretiminde pazar liderli\u011fi<\/p>\n<p><strong>2030 Vizyonu<\/strong>: 60-65 $<br \/> \u00d6zel ila\u00e7larda potansiyel sat\u0131n alma hedefi veya ba\u011f\u0131ms\u0131z b\u00fcy\u00fcme hikayesi<\/p>\n<p><strong>Karar<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Mevcut fiyat, tahmini adil de\u011ferin <strong>%63,9 alt\u0131nda<\/strong> i\u015flem g\u00f6rerek \u00f6nemli bir d\u00fc\u015f\u00fck de\u011ferlemeyi temsil ediyor.<\/p>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Ana Riskler<\/h3>\n<ol>\n<li><strong>Reg\u00fclasyon Zorluklar\u0131<\/strong>: FDA onaylar\u0131 \u00f6ng\u00f6r\u00fclemez olabilir &#8211; \u015firket 2017&#8217;de intranazal nalokson cihaz\u0131 i\u00e7in reddedilme ya\u015fad\u0131<\/li>\n<li><strong>Rekabetin Artmas\u0131<\/strong>: Artan jenerik rekabet marjlar\u0131 daha da bask\u0131layabilir<\/li>\n<li><strong>Gelir D\u00fc\u015f\u00fc\u015fleri<\/strong>: Mevcut %4,4 gelir b\u00fcy\u00fcmesinin tersine d\u00f6nmesi gerekiyor<\/li>\n<li><strong>Nakit Ak\u0131\u015f\u0131 Belirsizli\u011fi<\/strong>: Serbest nakit ak\u0131\u015f\u0131 pozisyonu hakk\u0131nda \u00e7eli\u015fkili raporlar belirsizlik yarat\u0131yor<\/li>\n<\/ol>\n<h3>2025 \u0130\u00e7in Olumlu \u0130\u015faretler<\/h3>\n<ol>\n<li><strong>453 Milyon $ Lisans Anla\u015fmas\u0131<\/strong>: Nanjing Anji Biotechnology ile \u00fc\u00e7 peptid ilac\u0131 i\u00e7in m\u00fcnhas\u0131r anla\u015fma<\/li>\n<li><strong>BAQSIMI G\u00fcc\u00fc<\/strong>: Amiral gemisi \u00fcr\u00fcn \u00e7eyreklik sat\u0131\u015f rekorlar\u0131 k\u0131r\u0131yor<\/li>\n<li><strong>Sekt\u00f6r Pozisyonu<\/strong>: Teknik \u00fcretim avantajlar\u0131na sahip 22 FDA onayl\u0131 \u00fcr\u00fcn<\/li>\n<li><strong>D\u00fc\u015f\u00fck De\u011ferleme<\/strong>: Adil de\u011fer tahminlerine g\u00f6re derin indirimle i\u015flem g\u00f6r\u00fcyor<\/li>\n<\/ol>\n<h2>\ud83c\udfaf Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5&#8217;inden fazla olmayan bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: \u00d6n\u00fcm\u00fczdeki 2-3 ay i\u00e7inde kademeli al\u0131mlar yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>10 Kas\u0131m \u0130\u00e7in Uyar\u0131 Ayarlay\u0131n<\/strong>: Rapor beklentileri a\u015farsa hemen harekete ge\u00e7meye haz\u0131r olun<\/li>\n<li><strong>Uzun Vadeli D\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu, h\u0131zl\u0131 bir i\u015flem de\u011fil, 2-3 y\u0131ll\u0131k bir yat\u0131r\u0131m hikayesidir<\/li>\n<\/ol>\n<p><strong>Esprili deneyimli tavsiye<\/strong>: &#8220;AMPH ticareti, hastane dramas\u0131n\u0131 izlemek gibidir &#8211; \u00e7ok ini\u015f \u00e7\u0131k\u0131\u015f var ama doktorlar sonunda hastay\u0131 genellikle kurtar\u0131r. Reklam aralar\u0131nda panik yapmay\u0131n!&#8221;<\/p>\n<h2>\u2705 Ad\u0131m Ad\u0131m: Amphastar Pharmaceuticals (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;AMPH&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>Do\u011fru sonu\u00e7lar i\u00e7in tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>\u0130\u015flem \u00f6ncesi emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Fiyat Uyar\u0131lar\u0131 Ayarlay\u0131n<\/td>\n<td>29 $ destek ve 35 $ diren\u00e7 seviyelerini izleyin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u00c7\u0131k\u0131\u015f Stratejinizi Planlay\u0131n<\/td>\n<td>K\u00e2r alma ve zarar durdurma seviyelerini \u00f6nceden belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option AMPH Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Mant\u0131kl\u0131?<\/h2>\n<p>AMPH gibi hisselerde pozisyon olu\u015fturmak isteyenler i\u00e7in Pocket Option, ila\u00e7 yat\u0131r\u0131m\u0131yla m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p>\n<p><strong>Minimum Para Yat\u0131rma Esnekli\u011fi<\/strong>: Sadece 5 $ ile ba\u015flayarak, AMPH ile stratejileri b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc olmadan test edebilirsiniz. Bu, daha b\u00fcy\u00fck yat\u0131r\u0131mlar yapmadan \u00f6nce g\u00fcven olu\u015fturmak i\u00e7in idealdir.<\/p>\n<p><strong>H\u0131zl\u0131 Hesap Do\u011frulama<\/strong>: 1 dakikal\u0131k KYC s\u00fcreci, kazan\u00e7 tarihleri veya son dakika haberlerine h\u0131zl\u0131 yan\u0131t vermenizi sa\u011flar.<\/p>\n<p><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: 100&#8217;den fazla y\u00f6ntemle, ba\u015far\u0131l\u0131 AMPH i\u015flemlerinden elde edilen k\u00e2rlar\u0131 tercih etti\u011finiz \u00f6deme kanal\u0131yla \u00e7ekebilirsiniz.<\/p>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, AMPH gibi karma\u015f\u0131k ila\u00e7 hisselerini yeni ba\u015flayanlar i\u00e7in eri\u015filebilir k\u0131larken, geli\u015fmi\u015f grafik ara\u00e7lar\u0131 bilin\u00e7li kararlar i\u00e7in gereken teknik analiz yeteneklerini sa\u011flar.<\/p>\n<h2>\ud83c\udfe5 Amphastar 2025&#8217;te: Uzmanla\u015fm\u0131\u015f \u0130la\u00e7 Lideri<\/h2>\n<p>Amphastar Pharmaceuticals, teknik a\u00e7\u0131dan zorlu ila\u00e7 \u00fcr\u00fcnlerinin dikey entegre \u00fcreticisi olarak benzersiz bir ni\u015f olu\u015fturdu. \u015eirket, steril enjeksiyonlar, inhalasyon \u00fcr\u00fcnleri ve ins\u00fclin API&#8217;lerinin aseptik dolum hatlar\u0131na sahip birden fazla \u00fcretim tesisi i\u015fletmektedir.<\/p>\n<p><strong>G\u00fcncel Piyasa Konumu<\/strong>: <\/p>\n<ul>\n<li>Piyasa de\u011feri: 1,42 milyar $<\/li>\n<li>Portf\u00f6yde 22 FDA onayl\u0131 \u00fcr\u00fcn<\/li>\n<li>Hastane ve acil bak\u0131m ortamlar\u0131na odaklanm\u0131\u015f<\/li>\n<li>Grup sat\u0131n alma organizasyonlar\u0131 ve toptanc\u0131lar arac\u0131l\u0131\u011f\u0131yla hizmet veriyor<\/li>\n<\/ul>\n<p>\u015eirketin Nanjing Anji Biotechnology ile yapt\u0131\u011f\u0131 \u00fc\u00e7 yenilik\u00e7i peptid ilac\u0131 i\u00e7in m\u00fcnhas\u0131r lisans anla\u015fmas\u0131, jeneriklerin \u00f6tesinde \u00f6zel \u00fcr\u00fcn hatt\u0131n\u0131 geni\u015fletme taahh\u00fcd\u00fcn\u00fc g\u00f6steriyor.<\/p>\n<p><strong>\u0130lgin\u00e7 2025 Ger\u00e7e\u011fi<\/strong>: Amphastar&#8217;\u0131n Rancho Cucamonga, Kaliforniya&#8217;daki genel merkezi, her kat\u0131n haftal\u0131k olarak \u00e7al\u0131\u015fanlar taraf\u0131ndan se\u00e7ilen farkl\u0131 bir terap\u00f6tik koku yayd\u0131\u011f\u0131 parf\u00fcm da\u011f\u0131t\u0131m sistemlerine sahip son teknoloji \u00fcretim tesislerine ev sahipli\u011fi yap\u0131yor &#8211; bu, ila\u00e7 uzmanl\u0131klar\u0131n\u0131 yans\u0131tan benzersiz bir duyusal deneyim yarat\u0131yor!<\/p>\n"},"faq":[{"question":"Amphastar Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"AMPH\" sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak al\u0131m yap\u0131n ve fiyat uyar\u0131lar\u0131 ile \u00e7\u0131k\u0131\u015f stratejinizi planlay\u0131n."},{"question":"AMPH hisseleri i\u00e7in 2025 fiyat hedefi nedir?","answer":"2025 y\u0131l sonu i\u00e7in fiyat hedefi 33-36 $ aral\u0131\u011f\u0131nda olup, mevcut seviyelerden %10-18 aras\u0131nda bir y\u00fckseli\u015f potansiyeli ta\u015f\u0131maktad\u0131r."},{"question":"AMPH hisselerinin riskleri nelerdir?","answer":"Reg\u00fclasyon zorluklar\u0131, artan rekabet, gelir d\u00fc\u015f\u00fc\u015fleri ve nakit ak\u0131\u015f\u0131 belirsizli\u011fi ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"AMPH hisseleri i\u00e7in uzun vadeli yat\u0131r\u0131m tavsiyesi nedir?","answer":"Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in AMPH hisseleri g\u00fc\u00e7l\u00fc al\u0131m \u00f6nerilir; yat\u0131r\u0131m 2-3 y\u0131l perspektifiyle d\u00fc\u015f\u00fcn\u00fclmelidir."},{"question":"Pocket Option AMPH yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 hesap do\u011frulama ve \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ile yeni ba\u015flayanlar i\u00e7in ideal bir platformdur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Amphastar Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"AMPH\" sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak al\u0131m yap\u0131n ve fiyat uyar\u0131lar\u0131 ile \u00e7\u0131k\u0131\u015f stratejinizi planlay\u0131n."},{"question":"AMPH hisseleri i\u00e7in 2025 fiyat hedefi nedir?","answer":"2025 y\u0131l sonu i\u00e7in fiyat hedefi 33-36 $ aral\u0131\u011f\u0131nda olup, mevcut seviyelerden %10-18 aras\u0131nda bir y\u00fckseli\u015f potansiyeli ta\u015f\u0131maktad\u0131r."},{"question":"AMPH hisselerinin riskleri nelerdir?","answer":"Reg\u00fclasyon zorluklar\u0131, artan rekabet, gelir d\u00fc\u015f\u00fc\u015fleri ve nakit ak\u0131\u015f\u0131 belirsizli\u011fi ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"AMPH hisseleri i\u00e7in uzun vadeli yat\u0131r\u0131m tavsiyesi nedir?","answer":"Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in AMPH hisseleri g\u00fc\u00e7l\u00fc al\u0131m \u00f6nerilir; yat\u0131r\u0131m 2-3 y\u0131l perspektifiyle d\u00fc\u015f\u00fcn\u00fclmelidir."},{"question":"Pocket Option AMPH yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 hesap do\u011frulama ve \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ile yeni ba\u015flayanlar i\u00e7in ideal bir platformdur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T08:18:20+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-30T08:18:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/\",\"name\":\"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"datePublished\":\"2025-08-30T08:18:20+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/","og_locale":"tr_TR","og_type":"article","og_title":"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T08:18:20+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-30T08:18:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/","name":"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","datePublished":"2025-08-30T08:18:20+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Amphastar Pharmaceuticals, Inc. (AMPH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Amphastar Pharmaceuticals, Inc. (AMPH) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":359171,"slug":"how-to-buy-amphastar-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Amphastar Pharmaceuticals, Inc. (AMPH) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Amphastar Pharmaceuticals, Inc. (AMPH)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":359174,"slug":"how-to-buy-amphastar-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Amphastar Pharmaceuticals, Inc. (AMPH) - Investimento em a\u00e7\u00f5es da Amphastar Pharmaceuticals, Inc. (AMPH)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-amphastar-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/359170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=359170"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/359170\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334063"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=359170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=359170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=359170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}